These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 12529975
1. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H. Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975 [Abstract] [Full Text] [Related]
2. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. Kato H, Nakajima M, Masuda N, Faried A, Sohda M, Fukai Y, Miyazaki T, Fukuchi M, Tsukada K, Kuwano H. J Surg Oncol; 2005 May 01; 90(2):89-94. PubMed ID: 15844180 [Abstract] [Full Text] [Related]
3. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. Kato H, Miyazaki T, Fukai Y, Nakajima M, Sohda M, Takita J, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Asao T, Kuwano H. J Surg Oncol; 2003 Sep 01; 84(1):24-30. PubMed ID: 12949987 [Abstract] [Full Text] [Related]
4. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Mineta H, Miura K, Takebayashi S, Misawa K, Araki K, Misawa Y, Ueda Y. Anticancer Res; 2002 Sep 01; 22(6B):3489-94. PubMed ID: 12552944 [Abstract] [Full Text] [Related]
5. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Anticancer Res; 2002 Sep 01; 22(6C):3977-84. PubMed ID: 12553021 [Abstract] [Full Text] [Related]
6. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. Ohba S, Fujii H, Ito S, Fujimaki M, Matsumoto F, Furukawa M, Yokoyama J, Kusunoki T, Ikeda K, Hino O. J Oral Pathol Med; 2010 Jan 01; 39(1):74-8. PubMed ID: 19709351 [Abstract] [Full Text] [Related]
7. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
14. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Takahashi Y, Noguchi T, Takeno S, Kimura Y, Okubo M, Kawahara K. Oncol Rep; 2006 Feb 15; 15(2):323-8. PubMed ID: 16391849 [Abstract] [Full Text] [Related]
15. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Ann Surg Oncol; 2009 Sep 15; 16(9):2494-501. PubMed ID: 19526206 [Abstract] [Full Text] [Related]
18. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma. Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Kita Y, Tamotsu K, Hanazono K, Owaki T, Aikou T. Oncol Rep; 2009 Jan 15; 21(1):65-71. PubMed ID: 19082444 [Abstract] [Full Text] [Related]